Dr. Ran Abuhasira was awarded a Fulbright postdoctoral fellowship to conduct research in the Division of Rheumatology, Allergy, and Immunology at Massachusetts General Hospital and in the Department of Medicine at Harvard Medical School. His research applies proteomics to identify protein signatures that reflect genetic, environmental, and metabolic pathways involved in the onset and progression of gout. By uncovering these markers, he aims to enhance risk prediction, improve disease prognosis, and advance personalized strategies for the prevention and management of gout and related metabolic-inflammatory conditions.

Ran is a senior physician in an internal medicine department and head of the Clinical Research Center at Soroka University Medical Center in Beer Sheva, Israel. He holds an MD/PhD from Ben-Gurion University of the Negev, where he graduated summa cum laude. His PhD in epidemiology, supervised by Professor Victor Novack, focused on the safety and efficacy of medical cannabis in older adults. He completed his internship at Assuta Ashdod Hospital and his residency in internal medicine at Rabin Medical Center.

Selected Publications:

Abuhasira R, Haviv YS, Leiba M, Leiba A, Ryvo L, Novack V. Cannabis Is Associated with Blood Pressure Reduction in Older Adults – A 24-Hours Ambulatory Blood Pressure Monitoring Study. Eur J Intern Med. 2021 Apr; 86:79–85.

Abuhasira R, Anstey M, Novack V, Bose S, Talmor D, Fuchs L. Intensive care unit capacity and mortality in older adults: a three nations retrospective observational cohort study. Ann Intensive Care. 2022 Mar 4;12(1):20.

Abuhasira R, Burrack N, Turjeman A, Patt YS, Leibovici L, Grossman A. Comparative Analysis of First-Line Antihypertensive Treatment Classes. Am J Med. 2025 Mar;138(3):449–457.e7.